Liver Immune Tolerance Marker Utilization Study
NCT02541916
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
69
Enrollment
OTHER
Sponsor class
Conditions
Immunosuppression
Immune Tolerance
Interventions
OTHER:
Controlled weaning of immunosuppression
Sponsor
University of Toronto